Marksans Pharma raises Rs 372.40 crore in equity via conversion of warrants issued to OrbiMed and… EP News Bureau Jan 20, 2023 The warrants are converted at a price of Rs 74 per share, reflecting the promoter's and OrbiMed's commitment to the company
